title: Response to: 'Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?' by Giannopoulos and Deftereos.
authors.affiliation: Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Solomon
authors.affiliation: Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Seoyoung C
authors.initials: SC
authors.lastname: Kim
mesh_terms: D003078:Colchicine / Q000627:therapeutic use*; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D012306:Risk
chemical_list: D006074:Gout Suppressants; D003078:Colchicine
keywords: Cardiovascular Disease; Disease Activity; Gout